| Multi-country evaluation of RISK6, a 6-gene blood transcriptomic signature, for tuberculosis diagnosis and treatment monitoring R Bayaa, MDB Ndiaye, C Chedid, E Kokhreidze, N Tukvadze, S Banu, ... Scientific Reports 11 (1), 13646, 2021 | 20 | 2021 |
| Seroprevalence of ancestral and Beta SARS-CoV-2 antibodies in Malagasy blood donors SL Razafimahatratra, MDB Ndiaye, LT Rasoloharimanana, P Dussart, ... The Lancet global health 9 (10), e1363-e1364, 2021 | 10 | 2021 |
| Plasma host protein signatures correlating with Mycobacterium tuberculosis activity prior to and during antituberculosis treatment MDB Ndiaye, P Ranaivomanana, LT Rasoloharimanana, V Rasolofo, ... Scientific Reports 12 (1), 20640, 2022 | 7 | 2022 |
| Using a multiplex serological assay to estimate time since SARS-CoV-2 infection and past clinical presentation in malagasy patients MDB Ndiaye, LT Rasoloharimanana, SL Razafimahatratra, R Ratovoson, ... Heliyon 9 (6), 2023 | 4 | 2023 |
| Different PPD-stimulated cytokine responses from patients infected with genetically distinct Mycobacterium tuberculosis complex lineages P Ranaivomanana, MS Rabodoarivelo, MDB Ndiaye, ... International Journal of Infectious Diseases 104, 725-731, 2021 | 4 | 2021 |
| C1q and HBHA-specific IL-13 levels as surrogate plasma biomarkers for monitoring tuberculosis treatment efficacy: a cross-sectional cohort study in Paraguay G Russomando, D Sanabria, CC Díaz Acosta, L Rojas, L Franco, ... Frontiers in Immunology 15, 1308015, 2024 | | 2024 |
